Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right nowByBruce GilPublishedOctober 2, 2024
The Dow closes 500 points lower as jobless claims rise and investors feel hopeless about interest rate cutsByVinamrata ChaturvediUpdatedAugust 1, 2024
Companies are failing to train their employees on AI — so they ‘go rogue’ByLaura BrattonPublishedJuly 30, 2024
Eli Lilly's latest deal added $200 million to a Harvard professor's billion-dollar fortuneByBruce GilPublishedJuly 9, 2024
JPMorgan's Ozempic bet, J&J's baby powder settlement, Moderna's COVID-flu vax: Pharma news round upByBruce GilPublishedJune 14, 2024
Moderna's COVID-flu combo shot outperformed existing vaccines in a late-stage trialByBruce GilUpdatedJune 10, 2024
Ozempic competitors, psychedelic stocks, and Moderna after COVID: Pharma news roundupByBruce GilPublishedJune 7, 2024
Moderna just got FDA approval for its RSV vaccine — only its second product on the marketByBruce GilPublishedMay 31, 2024
Ozempic supply trackers, bird flu vaccines, and Merck's future: Pharma news roundupByBruce GilPublishedMay 31, 2024
